November 5, 2025 — Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) will release its third quarter 2025 financial and operating results after market close on Wednesday, November 12, 2025. Management will host a webcast and conference call to discuss the results and provide a corporate update.
Conference call details include:
- Date: Wednesday, November 12, 2025
- Time: 5:00 pm Eastern Time
- Dial-In Numbers: 1-800-717-1738 (Canada and the United States) or 1-646-307-1865 (International)
The call will also be broadcast live and archived on the Company’s website.
Perimeter Medical Imaging AI (TSX-V: PINK) (OTCQX: PYNKF) is a medical technology company focused on cancer surgery with ultra-high-resolution, real-time, advanced imaging tools. The FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The investigational Perimeter B-Series OCT with ImgAssist AI is being evaluated in a pivotal clinical trial, supported by a grant of up to US$7.4 million from the Cancer Prevention and Research Institute of Texas.
Perimeter B-Series OCT is limited to investigational use and not available for sale in the United States. Perimeter S-Series OCT has 510(k) clearance under a general indication and has not been evaluated by the U.S. FDA specifically for use in breast tissue, breast cancer, other types of cancer, margin evaluation, and reducing re-excision rates.
Contacts:
Stephen Kilmer
Investor Relations
Direct: 647-872-4849
Email: skilmer@perimetermed.com
Adrian Mendes
Chief Executive Officer
Toll-free: 888-988-7465 (PINK)
Email: investors@perimetermed.com
TORONTO and DALLAS — November 5, 2025 — Leads & Copy —
Source: Perimeter Medical Imaging AI Inc.
